RRC
60
-3
KO
44
2
OMC
64
-2
FRT
48
2
XEL
65
-2
ZTS
49
2
NSC
64
2
GPC
40
2
PWR
71
-3
DD
61
4
LOW
58
2
NRG
50
-2
JCI
61
-2
TRV
56
-2
DVN
29
4
EXR
59
4
DRI
56
2
TROW
51
-2
LEG
31
3
KLAC
45
-4
RRC
60
-3
KO
44
2
OMC
64
-2
FRT
48
2
XEL
65
-2
ZTS
49
2
NSC
64
2
GPC
40
2
PWR
71
-3
DD
61
4
LOW
58
2
NRG
50
-2
JCI
61
-2
TRV
56
-2
DVN
29
4
EXR
59
4
DRI
56
2
TROW
51
-2
LEG
31
3
KLAC
45
-4
Financhill
Back

Arbutus Biopharma Vs. Amicus Therapeutics Industry Stock Comparison

Sell
41

ABUS
Arbutus Biopharma

Last Price:
3.63
Seasonality Move:
13.65%
Sell
44

FOLD
Amicus Therapeutics

Last Price:
10.10
Seasonality Move:
8.32%
Sell
41
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.65. The Score for ABUS is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $10.38. The Score for FOLD is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $10.38
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing selling pressure, which indicates risk of future bearish movement.

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 36.73 Sell
Chaikin Money Flow: -592634 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.77 - 4.07) Sell
Bollinger Bands (100): (3.49 - 4.15) Sell

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.09 Sell
Relative Strength Index (14 RSI): 36.89 Sell
Chaikin Money Flow: -1470064 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.52 - 11.72) Sell
Bollinger Bands (100): (10.2 - 11.54) Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.78 Sell
20-day SMA: 3.93 Sell
50-day SMA: 4.02 Sell
200-day SMA: 3.34 Buy
8-day EMA: 3.76 Sell
20-day EMA: 3.86 Sell
50-day EMA: 3.89 Sell
200-day EMA: 3.42 Buy

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 10.98 Sell
20-day SMA: 11.32 Sell
50-day SMA: 11.06 Sell
200-day SMA: 11.08 Sell
8-day EMA: 10.86 Sell
20-day EMA: 11.06 Sell
50-day EMA: 11.04 Sell
200-day EMA: 11.1 Sell

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):